|
|
> > Most Dissatisfied With Allergy Meds
|
Most Dissatisfied With Allergy Meds
|
THURSDAY, March 30 (HealthDay News) -- Nearly a third (31 percent) of allergy
patients aren't satisfied with their current prescription allergy medication, and 60 percent
said they're very interested in finding a new drug, according to a survey released last
week by the Asthma and Allergy Foundation of America (AAFA).
Among respondents not fully satisfied with their current prescription allergy medication,
55 percent said their current medication does not relieve their allergy symptoms for a
long enough period of time, and 44 percent said their medication doesn't provide quick
enough relief.
The survey also found that 47 percent of patients are taking multiple allergy prescription
drugs. Thirty-six percent of those who take prescription allergy medications are also
using non-prescription allergy drugs.
"People are taking two, three, sometimes four different medications at a time to relieve
their symptoms quickly and effectively because they are increasingly unsatisfied with
their allergy medications. This can be a very costly, dangerous and frequently ineffective
solution to treating bothersome symptoms," Dr. Alpen Patel, a member of the AAFA's
medical-scientific council and an assistant professor in otolaryngology at George
Washington University Medical Center, said in a prepared statement.
Oral medications are the most commonly used form of prescription allergy medication
(67 percent), but 81 percent of respondents said they'd be willing to try a nasal spray to
treat their allergy symptoms.
About half (51 percent) of the patients who said they'd consider switching medications
said they're confused by all the different choices, and 59 percent said they wished they
knew more about the different kinds of available allergy medications.
"Nearly 30 percent of patients admit they don't even know what type of allergy
medication they are taking, whether it is an antihistamine or an anti-inflammatory steroid
drug. The survey findings suggest the need for patients to have open dialogues with their
doctors about the allergy medications they are taking and available treatment options out
there," Patel said.
The study was funded by a grant from Alcon Laboratories Inc., which makes Patanol, an
eye allergy medication.
More information
The American Lung Association has more about allergies.
Download pdf
|
|
|
